The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrative molecular profiling challenges robustness of prognostic signature scores in multifocal prostate cancer.
 
Daniel Hovelson
No Relationships to Disclose
 
Simpa Samuel Salami
No Relationships to Disclose
 
Jeremy B Kaplan
No Relationships to Disclose
 
Romain Mathieu
No Relationships to Disclose
 
Aaron Udager
No Relationships to Disclose
 
Nicole Curci
No Relationships to Disclose
 
Matthew Lee
No Relationships to Disclose
 
Lorena Lazo De La Vega
No Relationships to Disclose
 
Martin Susani
No Relationships to Disclose
 
Nathalie Rioux-Leclercq
No Relationships to Disclose
 
Daniel Eidelberg Spratt
No Relationships to Disclose
 
Todd Matthew Morgan
Consulting or Advisory Role - MDxHealth; Myriad Genetics
Research Funding - GenomeDx (Inst); MDxHealth (Inst); Myriad Genetics (Inst)
 
Matthew Davenport
No Relationships to Disclose
 
Mark A. Rubin
Research Funding - Janssen; Lilly
 
Shahrokh F. Shariat
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent US07759077; Patent US20030054419; Patent US20030235816; Patent US2003235816
 
Scott A. Tomlins
Leadership - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
Consulting or Advisory Role - Abbvie; Almac Diagnostics; Astellas Medivation; Janssen; Roche; Sanofi; Strata Oncology; Ventana Medical Systems
Research Funding - Astellas Medivation (Inst); Compendia Bioscience (Inst); GenomeDx (Inst); Life Technologies (Inst); Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - I am a coauthor on a patent issued to the University of Michigan on ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe Inc., who has sublicensed some rights to Ventana Medical Systems/Roche.
Travel, Accommodations, Expenses - Compendia Bioscience; Life Technologies; Strata Oncology; Thermo Fisher Scientific
 
Ganesh S. Palapattu
Stock and Other Ownership Interests - NantWorks
Consulting or Advisory Role - GenomeDx; Tokai Pharmaceuticals
Research Funding - NantWorks
Patents, Royalties, Other Intellectual Property - implantable nanotechnology for long term testosterone delivery functionalized fiducial marker for drug delivery
Travel, Accommodations, Expenses - Tokai Pharmaceuticals